Miller TR - Search Results

1

Species-related pharmacological heterogeneity of histamine H(3) receptors.

Ireland-Denny L, Parihar AS, Miller TR, Kang CH, Krueger KM, Esbenshade TA, Hancock AA. Ireland-Denny L, et al. Among authors: miller tr. Eur J Pharmacol. 2001 Dec 21;433(2-3):141-50. doi: 10.1016/s0014-2999(01)01518-7. Eur J Pharmacol. 2001. PMID: 11755145

2

Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 2: binding preference for D-amino acids motifs.

Faghih R, Dwight W, Black L, Liu H, Gentles R, Phelan K, Esbenshade TA, Ireland L, Miller TR, Kang CH, Krueger KM, Fox GB, Hancock AA, Bennani YL. Faghih R, et al. Among authors: miller tr. Bioorg Med Chem Lett. 2002 Aug 5;12(15):2035-7. doi: 10.1016/s0960-894x(02)00310-4. Bioorg Med Chem Lett. 2002. PMID: 12113836

3

Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects.

Esbenshade TA, Krueger KM, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Fox GB, Faghih R, Bennani YL, Williams M, Hancock AA. Esbenshade TA, et al. Among authors: miller tr. J Pharmacol Exp Ther. 2003 Jun;305(3):887-96. doi: 10.1124/jpet.102.047183. Epub 2003 Feb 20. J Pharmacol Exp Ther. 2003. PMID: 12606603

4

Differential activation of dual signaling responses by human H1 and H2 histamine receptors.

Esbenshade TA, Kang CH, Krueger KM, Miller TR, Witte DG, Roch JM, Masters JN, Hancock AA. Esbenshade TA, et al. Among authors: miller tr. J Recept Signal Transduct Res. 2003 Feb;23(1):17-31. doi: 10.1081/rrs-120018758. J Recept Signal Transduct Res. 2003. PMID: 12680587

5

Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 3: 5-Substituted 3-phenyl-1,2,4-oxadiazoles as potent antagonists.

Gfesser GA, Zhang H, Dinges J, Fox GB, Pan JB, Esbenshade TA, Yao BB, Witte D, Miller TR, Kang CH, Krueger KM, Bennani YL, Hancock AA, Faghih R. Gfesser GA, et al. Among authors: miller tr. Bioorg Med Chem Lett. 2004 Feb 9;14(3):673-6. doi: 10.1016/j.bmcl.2003.11.038. Bioorg Med Chem Lett. 2004. PMID: 14741266

6

Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist.

Esbenshade TA, Fox GB, Krueger KM, Baranowski JL, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Pan JB, Faghih R, Bennani YL, Williams M, Hancock AA. Esbenshade TA, et al. Among authors: miller tr. Biochem Pharmacol. 2004 Sep 1;68(5):933-45. doi: 10.1016/j.bcp.2004.05.048. Biochem Pharmacol. 2004. PMID: 15294456

7

In vitro optimization of structure activity relationships of analogues of A-331440 combining radioligand receptor binding assays and micronucleus assays of potential antiobesity histamine H3 receptor antagonists.

Hancock AA, Diehl MS, Faghih R, Bush EN, Krueger KM, Krishna G, Miller TR, Wilcox DM, Nguyen P, Pratt JK, Cowart MD, Esbenshade TA, Jacobson PB. Hancock AA, et al. Among authors: miller tr. Basic Clin Pharmacol Toxicol. 2004 Sep;95(3):144-52. doi: 10.1111/j.1742-7843.2004.950307.x. Basic Clin Pharmacol Toxicol. 2004. PMID: 15447739 Free article.

8

Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like properties.

Esbenshade TA, Fox GB, Krueger KM, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Pan L, Wetter J, Marsh K, Bennani YL, Cowart MD, Sullivan JP, Hancock AA. Esbenshade TA, et al. Among authors: miller tr. J Pharmacol Exp Ther. 2005 Apr;313(1):165-75. doi: 10.1124/jpet.104.078303. Epub 2004 Dec 17. J Pharmacol Exp Ther. 2005. PMID: 15608078

9

G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations.

Krueger KM, Witte DG, Ireland-Denny L, Miller TR, Baranowski JL, Buckner S, Milicic I, Esbenshade TA, Hancock AA. Krueger KM, et al. Among authors: miller tr. J Pharmacol Exp Ther. 2005 Jul;314(1):271-81. doi: 10.1124/jpet.104.078865. Epub 2005 Apr 8. J Pharmacol Exp Ther. 2005. PMID: 15821027

10

Detection of multiple H3 receptor affinity states utilizing [3H]A-349821, a novel, selective, non-imidazole histamine H3 receptor inverse agonist radioligand.

Witte DG, Yao BB, Miller TR, Carr TL, Cassar S, Sharma R, Faghih R, Surber BW, Esbenshade TA, Hancock AA, Krueger KM. Witte DG, et al. Among authors: miller tr. Br J Pharmacol. 2006 Jul;148(5):657-70. doi: 10.1038/sj.bjp.0706752. Epub 2006 May 22. Br J Pharmacol. 2006. PMID: 16715122 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

758 results

Search Page

Filters